Dopaminergic differentiation of stem cells from human deciduous teeth and their therapeutic benefits for Parkinsonian rats

Brain Research

Volumn 1613, Issue , 2015, Pages 59-72

  Fujii, Hiromi ^a   Matsubara, Kohki ^a   Sakai, Kiyoshi ^a   Ito, Mikako ^a   Ohno, Kinji ^a   Ueda, Minoru ^a   Yamamoto, Akihito ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopaminergic (DAergic) neurons; Neuroprotection; Neurotrophic factors; Parkinson's disease; Stem cells derived from human exfoliated deciduous teeth (SHEDs); Transplantation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROGENIN 2; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; OXIDOPAMINE; SCATTER FACTOR; TRANSCRIPTION FACTOR MASH1; ASCL1 PROTEIN, RAT; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; NERVE PROTEIN; NGN2 PROTEIN, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; CHILD; CONTROLLED STUDY; DECIDUOUS TOOTH; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; MASH1 GENE; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROPROTECTION; NEUROTOXICITY; NGN2 GENE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL TRANSPLANTATION; TOOTH PULP; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; METABOLISM; NEURAL STEM CELL; PARKINSON DISEASE; PHYSIOLOGY; TRANSPLANTATION;

PARKINSONIA; RATTUS;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL SURVIVAL; CHILD; DOPAMINERGIC NEURONS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HUMANS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; PARKINSON DISEASE; RATS; TOOTH, DECIDUOUS;

EID: 84930086753     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.04.001     Document Type: Article

References (55)

1. S.L. Ang Transcriptional control of midbrain dopaminergic neuron development Development 133 2006 3499 3506
2. C. Apel The neuroprotective effect of dental pulp cells in models of Alzheimer's and Parkinson's disease J. Neural Transm. 116 2009 71 78
3. Z.C. Baquet, P.C. Bickford, and K.R. Jones Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta J. Neurosci. 25 2005 6251 6259
4. R. Barzilay Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols Stem Cells Dev. 17 2008 547 554
5. K.C. Biju Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease Neurosci. Lett. 535 2013 24 29
6. H. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol. Aging 24 2003 197 211
7. C.S. Capitelli Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells Int. J. Med. Sci. 11 2014 1049 1064
8. L. Cova Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease Apoptosis 17 2012 289 304
9. J.L. Cummings Depression and Parkinson's disease: a review Am. J. Psychiatry 149 1992 443 454
10. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
11. M. Dezawa Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation J. Clin. Invest. 113 2004 1701 1710
12. L.M. Farkas Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo J Neurosci. 23 2003 5178 5186
13. E. Fernandez-Espejo Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies Mol. Neurobiol. 29 2004 15 30
14. C.R. Freed Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease N. Engl. J. Med. 327 1992 1549 1555
15. D.C. German Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization Ann. Neurol. 26 1989 507 514
16. A. Glavaski-Joksimovic Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease J. Neurosci. Res. 88 2010 2669 2681
17. A. Glavaski-Joksimovic, and M.C. Bohn Mesenchymal stem cells and neuroregeneration in Parkinson's disease Exp. Neurol. 247 2013 25 38
18. S. Gronthos Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo Proc. Natl. Acad. Sci. U.S.A. 97 2000 13625 13630
19. S. Gronthos Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo Proc. Natl. Acad. Sci. U.S.A. 97 2000 13625 13630
20. S. Gronthos Stem cell properties of human dental pulp stem cells J. Dent. Res. 81 2002 531 535
21. A. Hermann Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells J. Cell Sci. 117 2004 4411 4422
22. M. Hynes Induction of midbrain dopaminergic neurons by Sonic hedgehog Neuron 15 1995 35 44
23. M. Hynes, and A. Rosenthal Specification of dopaminergic and serotonergic neurons in the vertebrate CNS Curr. Opin. Neurobiol. 9 1999 26 36
24. T. Inoue Stem cells from human exfoliated deciduous tooth-derived conditioned medium enhance recovery of focal cerebral ischemia in rats Tissue Eng. Part A 19 2013 24 29
25. J. Jankovic, S. Chen, and W.D. Le The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease Prog. Neurobiol. 77 2005 128 138
26. M. Kanafi Midbrain cues dictate differentiation of human dental pulp stem cells towards functional dopaminergic neurons J. Cell Physiol. 229 2014 1369 1377
27. J. Kele Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons Development 133 2006 495 505
28. M. Kiraly Simultaneous PKC and cAMP activation induces differentiation of human dental pulp stem cells into functionally active neurons Neurochem. Int. 55 2009 323 332
29. D. Kirik, C. Rosenblad, and A. Bjorklund Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat Exp. Neurol. 152 1998 259 277
30. E.R. Kramer Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system PLoS Biol. 5 2007 e39
31. Y. Li Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron development Proc. Natl. Acad. Sci. U.S.A. 109 2012 15491 15496
32. O. Lindvall Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease Science 247 1990 574 577
33. M.K. McCoy Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease Exp. Neurol. 210 2008 14 29
34. M. Miura SHED: stem cells from human exfoliated deciduous teeth Proc. Natl. Acad. Sci. U.S.A. 100 2003 5807 5812
35. M. Miura SHED: stem cells from human exfoliated deciduous teeth Proc. Natl. Acad. Sci. U.S.A. 100 2003 5807 5812
36. V. Neirinckx Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play Stem Cells Transl. Med. 2 2013 284 296
37. M. Nieto Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors Neuron 29 2001 401 413
38. I.V. Nosrat Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system Eur. J. Neurosci. 19 2004 2388 2398
39. C.W. Olanow, J.H. Kordower, and T.B. Freeman Fetal nigral transplantation as a therapy for Parkinson's disease Trends Neurosci. 19 1996 102 109
40. H.J. Park Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a Parkinsonian model Neurobiol. Aging 35 2014 1920 1928
41. O. Sadan Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease Stem Cells Dev. 18 2009 1179 1190
42. K. Sakai Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms J. Clin. Invest. 122 2012 80 90
43. H. Sauer, and W.H. Oertel Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 59 1994 401 415
44. R. Somoza Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease Biol. Blood Marrow Transplant. 16 2010 1530 1540
45. L. Studer Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen J. Neurosci. 20 2000 7377 7383
46. K.A. Trzaska, E.V. Kuzhikandathil, and P. Rameshwar Specification of a dopaminergic phenotype from adult human mesenchymal stem cells Stem Cells 25 2007 2797 2808
47. J. Wang Stem cells from human-exfoliated deciduous teeth can differentiate into dopaminergic neuron-like cells Stem Cells Dev. 19 2010 1375 1383
48. Y. Wang Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson's disease PLoS One 8 2013 e54296
49. M.L. Weiss Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease Stem Cells 24 2006 781 792
50. M. Yamagata Human dental pulp-derived stem cells protect against hypoxic-ischemic brain injury in neonatal mice Stroke 44 2013 551 554
51. A. Yamamoto Multifaceted neuro-regenerative activities of human dental pulp stem cells for functional recovery after spinal cord injury Neurosci. Res. 78 2014 16 20
52. K. Yamanaka Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice Proc. Natl. Acad. Sci. U.S.A. 105 2008 7594 7599
53. K. Yamanaka Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis Nat. Neurosci. 11 2008 251 253
54. M. Yan Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model PLoS One 8 2013 e64000
55. F. Young, A. Sloan, and B. Song Dental pulp stem cells and their potential roles in central nervous system regeneration and repair J. Neurosci. Res. 91 2013 1383 1393